These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11062291)

  • 1. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease.
    Ito D; Murata M; Tanahashi N; Sato H; Sonoda A; Saito I; Watanabe K; Fukuuchi Y
    Stroke; 2000 Nov; 31(11):2661-4. PubMed ID: 11062291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: a meta-analysis.
    Banerjee I
    J Appl Genet; 2009; 50(2):153-7. PubMed ID: 19433913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction.
    Hashad IM; Hossni NM; Abdel Rahman MF; Shehata M; Shaban G; Gad MZ
    Curr Pharm Biotechnol; 2018; 19(4):336-342. PubMed ID: 29874995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction.
    Hubacek JA; Rothe G; Pit'ha J; Skodová Z; Stanĕk V; Poledne R; Schmitz G
    Circulation; 1999 Jun; 99(25):3218-20. PubMed ID: 10385492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.
    Unkelbach K; Gardemann A; Kostrzewa M; Philipp M; Tillmanns H; Haberbosch W
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):932-8. PubMed ID: 10195920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14.
    Obana N; Takahashi S; Kinouchi Y; Negoro K; Takagi S; Hiwatashi N; Shimosegawa T
    Scand J Gastroenterol; 2002 Jun; 37(6):699-704. PubMed ID: 12126249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population.
    Hung J; McQuillan BM; Chapman CM; Thompson PL; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2004 Aug; 11(4):344-9. PubMed ID: 15292769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the -159 C --> T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects.
    Eilertsen KE; Olsen JO; Brox J; ØSterud B
    Blood Coagul Fibrinolysis; 2003 Oct; 14(7):663-70. PubMed ID: 14517492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers.
    Campos J; Gonzalez-Quintela A; Quinteiro C; Gude F; Perez LF; Torre JA; Vidal C
    Alcohol Clin Exp Res; 2005 Jul; 29(7):1206-13. PubMed ID: 16046876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men.
    Shimada K; Watanabe Y; Mokuno H; Iwama Y; Daida H; Yamaguchi H
    Am J Cardiol; 2000 Sep; 86(6):682-4, A8. PubMed ID: 10980225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.
    Koenig W; Khuseyinova N; Hoffmann MM; März W; Fröhlich M; Hoffmeister A; Brenner H; Rothenbacher D
    J Am Coll Cardiol; 2002 Jul; 40(1):34-42. PubMed ID: 12103253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris.
    Karhukorpi J; Ikäheimo I; Karvonen J; Karttunen R
    Eur J Immunogenet; 2002 Feb; 29(1):57-60. PubMed ID: 11841490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-hoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease.
    Porsch-Ozcürümez M; Hucke J; Westphal S; Hubáček JA; Schmitz G; Luley C
    Physiol Res; 2007; 56(6):727-733. PubMed ID: 17087609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction.
    Longobardo MT; Cefalù AB; Pezzino F; Noto D; Emmanuele G; Barbagallo CM; Fiore B; Monastero R; Castello A; Molini V; Notarbartolo A; Travali S; Averna MR
    Clin Exp Med; 2003 Nov; 3(3):161-5. PubMed ID: 14648231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of promoter polymorphism of the CD14 C (-159) T endotoxin receptor gene with chronic hepatitis B.
    Mohammad Alizadeh AH; Ranjbar M; Hajilooi M; Fallahian F
    World J Gastroenterol; 2006 Sep; 12(35):5717-20. PubMed ID: 17007028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection.
    Eng HL; Chen CH; Kuo CC; Wu JS; Wang CH; Lin TM
    J Infect Dis; 2003 Jul; 188(1):90-7. PubMed ID: 12825176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.
    Ouburg S; Spaargaren J; den Hartog JE; Land JA; Fennema JS; Pleijster J; Peña AS; Morré SA;
    BMC Infect Dis; 2005 Dec; 5():114. PubMed ID: 16368002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.
    Karhukorpi J; Yan Y; Niemela S; Valtonen J; Koistinen P; Joensuu T; Saikku P; Karttunen R
    Clin Exp Immunol; 2002 May; 128(2):326-32. PubMed ID: 11985523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T; Klein W; Epplen JT; Hebler U; Stachon A; May B
    Hepatogastroenterology; 2005; 52(63):808-11. PubMed ID: 15966209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.